Mineralys Therapeutics, Inc. (MLYS)
(Delayed Data from NSDQ)
$11.87 USD
+0.83 (7.52%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $11.88 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/20/2024
Time: -- |
3/2024 | $-0.68 | 5.88% |
Earnings Summary
For their last quarter, Mineralys Therapeutics, Inc. (MLYS) reported earnings of -$0.61 per share, beating the Zacks Consensus Estimate of $-0.85 per share. This reflects a positive earnings surprise of 28.24%. Look out for MLYS's next earnings release expected on May 20, 2024. For the next earning release, we expect the company to report earnings of -$0.68 per share, reflecting a year-over-year decrease of 33.33%.
Earnings History
Price & Consensus
Zacks News for MLYS
Wall Street Analysts See a 199.3% Upside in Mineralys Therapeutics, Inc. (MLYS): Can the Stock Really Move This High?
MLYS: What are Zacks experts saying now?
Zacks Private Portfolio Services